Latest News
Where regulatory announcements include insider information, this is indicated in the announcement itself.
Date
Title
HTML
09 Nov 2021
Poseida Therapeutics Provides Program Updates and Financial Results for the Third Quarter of 2021
19 Oct 2021
Artizan Biosciences Announces Appointment of Dr. Bridget Martell as President and Chief Executive Officer
12 Oct 2021
Poseida Therapeutics Announces Research Collaboration with Takeda for Novel Non-Viral In Vivo Gene Therapies
01 Oct 2021
Poseida Therapeutics to Present at Society for Immunotherapy of Cancer 2021 Annual Meeting
12 Aug 2021
Poseida Therapeutics Reports Program Updates and Financial Results for the Second Quarter of 2021
19 May 2021
Immunocore announces dosing of first patient with ImmTAV® bispecific molecule for chronic Hepatitis B
11 May 2021
Poseida Therapeutics Reports Program Updates and Financial Results for the First Quarter 2021
06 May 2021
Poseida Therapeutics Announces Key Additions to Immuno-Oncology Scientific Advisory Board
27 Apr 2021
Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting
23 Mar 2021
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
11 Mar 2021
Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020
17 Feb 2021
EmitBio Demonstrates Statistically Significant Results in Clinical Trial for COVID-19 Treatment
03 Dec 2020
Immunocore presents Phase 2 tebentafusp clinical results at ESMO Immuno-Oncology Virtual Congress 2020
12 Nov 2020
Poseida Therapeutics Reports Operational Update and Financial Results for Third Quarter 2020
02 Nov 2020
Poseida Therapeutics Announces Clinical Hold Lifted on Phase I Autologous CAR-T Study in Prostate Cancer
15 Oct 2020
Immunocore Appoints Nobel Laureate Professor Sir Peter J. Ratcliffe as Non-Executive Director
16 Sep 2020
Poseida Therapeutics to Present CAR-T Manufacturing Process Optimization Data at CAR-TCR Digital Week 2020
11 Aug 2020
Kymab Announces Positive Phase 2a Results for KY1005 in Moderate to Severe Atopic Dermatitis
08 Jun 2020
Mycovia Pharmaceuticals to Participate in On-Demand Women’s Health Panel at BIO Digital 2020
19 May 2020
KNOW Bio – REVIAN RED Wins 2020 MedTech Breakthrough Award for Best New Dermatology Solution
06 Dec 2019
Kymab Presents Updates at the American Society of Hematology (ASH) 61st Annual Meeting and Exposition
21 Nov 2019
KNOW Bio – REVIAN® Names President to Commercialize Medical Grade LED Light Therapy for Hair Growth
08 Oct 2019
KNOW Bio – Vast Therapeutics Receives Qualified Infectious Disease Product Status for BIOC11
08 Oct 2019
Novan’s Phase 2 SB206 Molluscum Study Published in Journal of the American Academy of Dermatology
03 Oct 2019
Kymab Announces Presentation on KY1049 at the European Congress on Thrombosis and Haemostasis
27 Sep 2019
Kymab Outlines Positive New Findings for its KY1044 AntiICOS Program at the CICON 2019 Annual Meeting
05 Sep 2019
Novan and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $25 Million
08 Jul 2019
Xenex: LightStrike Robot Proven Effective at Destroying Deadly Superbug Candida Auris in New Published Study
09 May 2019
Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
07 May 2019
Melinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual Meeting
07 May 2019
Novan to Present Clinical Data at Annual Meeting of the Society for Investigative Dermatology
07 May 2019
Immunocore appoints Dr Mohammed Dar as Head of Clinical Development and Chief Medical Officer
03 Apr 2019
Immunocore’s Lead Asset Tebentafusp Gains Fast Track Designation for Metastatic Uveal Melanoma
05 Mar 2019
Melinta Therapeutics to Report Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019
20 Feb 2019
Mayo Clinic Study Reports 47% Reduction in C.diff Infection Rates Using Pulsed Xenon UV Room Disinfection
13 Feb 2019
Poseida Therapeutics Announces Notice of Allowance for New Patents and Registration of New Trademarks
19 Dec 2018
Melinta Therapeutics Announces Commitment for New Credit Facility of Up to $135 Million ~
19 Dec 2018
John H. Johnson Agrees to Become Permanent Chief Executive Officer of Melinta Therapeutics
19 Nov 2018
Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech
14 Nov 2018
Novan Phase 2 Molluscum Contagiosum Trial Achieves Statistical Significance in Preliminary Top Line Results
22 Oct 2018
Melinta Therapeutics Announces Appointment of John H. Johnson as Interim Chief Executive Officer
01 Oct 2018
Novan’s Phase 2 Molluscum Contagiosum Trial Fully Enrolled: Top Line Results Targeted in November
21 Sep 2018
Melinta Therapeutics Receives Positive CHMP Opinion for Vabomere™ (meropenem and vaborbactam)
06 Sep 2018
Melinta Therapeutics to Host Meetings at the Morgan Stanley 16th Annual Global Healthcare Conference
29 Aug 2018
Melinta Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
08 Aug 2018
Novan Provides Business Update via 10-Q, Adopts Incentive Plan and Agrees to CEO Contract
07 Aug 2018
Teneobio and Poseida Expand Their Partnership to Develop UniDabs™ for Advanced CAR-T Therapies
02 Mar 2018
Melinta Therapeutics to Present at The Cowen and Company 38th Annual Health Care Conference
28 Feb 2018
Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer
28 Feb 2018
Melinta Therapeutics To Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018
05 Feb 2018
Poseida Therapeutics Appoints Martin Giedlin, Ph.D., as Vice President, Technical Operations
18 Jan 2018
Melinta Therapeutics Announces Initiation of Program for Radezolid in Patients with Bacterial Vaginosis
11 Jan 2018
Xenex LightStrike Germ-Zapping Robots Helping Stanford Health Care – ValleyCare Destroy Germs and Bacteria
08 Jan 2018
Melinta Therapeutics Completes Acquisition of The Medicines Company’s Infectious Disease Portfolio
03 Jan 2018
NovaQuest Capital Management to Acquire Viamet Pharmaceuticals and the VT-1161 Antifungal Program
29 Nov 2017
Melinta Therapeutics Enters Into Agreement to Acquire Infectious Disease Business from The Medicines Company
21 Nov 2017
New Study Proves 2-Minute Cycle with Pulsed Xenon UV Significantly Reduces OR Contamination
07 Nov 2017
Novoclem Therapeutics Receives QIDP Status for Its Lead Inhaled Antimicrobial Drug Candidate
07 Nov 2017
Novan Announces Plan to Complete Development of SB204 Acne Candidate via Third Party Funding and Execution
02 Nov 2017
Novoclem Presents Promising New Data At The North America Cystic Fibrosis Conference on November 2, 2017
01 Nov 2017
Melinta and Cempra Announce Accomplished Executive Leadership Team for Combined Organization
10 Oct 2017
Melinta Therapeutics’ Topical Radezolid Well Tolerated in Phase 1 Study for Treatment of Acne
28 Sep 2017
Cempra and Melinta Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger
31 Jul 2017
Kymab Announces Clinical Update on its promising new antibody KY1005 for treatment of autoimmune diseases
27 Jul 2017
Viamet to Present Data on VT-1161 for the Treatment of Onychomycosis at the APMA Annual Meeting
07 Jul 2017
Immunocore and MEPC announce significant laboratory expansion at Milton Park in Oxfordshire, UK
03 Jul 2017
Immunocore announces third oncology target selected in discovery collaboration with GlaxoSmithKline
14 Jun 2017
Viamet to Participate in Antifungal Panel Discussion at the 2017 BIO International Convention
13 Jun 2017
Xenex Announces LightStrike Disinfection Pod™ – Industry’s First Mobile Equipment Disinfection System
05 Jun 2017
Melinta Therapeutics Demonstrates Potential of Pyrrolocytosine Candidate against Gonorrhea
01 Jun 2017
Melinta Therapeutics Presenting In Vivo and In Vitro Results from Baxdela Studies at ASM Microbe
01 Jun 2017
Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting
23 May 2017
Teneobio and Poseida Announce License Agreement for the Use of UniDab™ in CAR T-Cell Therapy
04 Apr 2017
3D4Medical announces the appointment of top medical professionals to its Medical Advisory Board
01 Mar 2017
Novan Announces Presentation of Anti-Viral Data at International Papillomavirus Conference
01 Mar 2017
Viamet Announces RENOVATE Phase 2b Onychomycosis Results to be Presented at the AAD 2017 Annual Meeting
28 Feb 2017
Melinta Announces FDA Acceptance of Investigational New Drug Application for Topical Radezolid
24 Feb 2017
Xenex Secures $38 Million in Funding Led by Essex Woodlands & Piper Jaffray Merchant Banking
06 Jan 2017
Viamet Reports Positive Results from RENOVATE Phase 2b Trial of Oral VT-1161 in Onychomycosis
26 Oct 2016
Melinta Therapeutics’ Baxdela™ to be Featured in Six Poster Presentations at IDWeek 2016™
24 Oct 2016
Melinta Therapeutics Submits Baxdela New Drug Application for Hospital-Treated Skin Infections
11 Oct 2016
Kymab and EpimAb Biotherapeutics Announce Multi-Target, Bispecific Antibody Cross-Licensing Agreement
19 Sep 2016
Viamet to Present at the 2016 Mycoses Study Group Education and Research Consortium Conference
01 Sep 2016
Award-winning medical platform ‘Complete Anatomy’ now available for Mac desktops and notebooks
13 Jul 2016
Viamet to Present Interim RENOVATE Results at the American Podiatric Medical Association 2016 Annual Meeting
15 Jun 2016
Melinta Therapeutics Presenting Results from Baxdela and ESKAPE Programs at ASM Microbe 2016 Meeting
01 Jun 2016
Viamet Receives Fast Track Designation from the FDA for VT-1129 for the Treatment of Cryptococcal Meningitis
25 May 2016
Viamet Receives Orphan Drug Designation from the FDA for VT-1598 for the Treatment of Coccidioidomycosis
02 Mar 2016
Viamet Reports Positive Results from Interim Analysis of RENOVATE Phase 2b Trial of VT-1161 in Onychomycosis
25 Jan 2016
Immunocore’s IMCgp100 Granted Orphan Drug Designation by US FDA for the Treatment of Uveal Melanoma
07 Jan 2016
Kymab and MD Anderson Announce Strategic Partnership in Immuno-Oncology Research & Development
06 Jan 2016
Immunocore and GlaxoSmithKline Select First ImmTAC Clinical Candidate in Discovery Collaboration
19 Nov 2015
EMBA Medical™ Limited Cleared to Market Hourglass™ Peripheral Embolization Plug in New Zealand
16 Nov 2015
Serenus Biotherapeutics to Launch Xenex UV Disinfection Robot at IPNET-K Conference 2015 in Naivasha, Kenya
07 Oct 2015
Serenus Biotherapeutics President Dr. Skhumbuzo Ngozwana to Participate in World Health Summit in Berlin
29 Sep 2015
Novan Announces Successful Phase 2b Clinical Trial Results with SB204 for the Treatment of Acne Vulgaris
17 Sep 2015
Serenus Biotherapeutics Partners With Xenex to Bring Xenex Disinfection Robots to Africa
07 Sep 2015
Immunocore Ranked No 1 South East Company in the Annual Sunday Times Hiscox Tech Track 100
27 Aug 2015
Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio
11 Aug 2015
Nicklaus Children’s Hospital Acquires Xenex Germ-Zapping Robot to Enhance Patient Safety
16 Jul 2015
Viamet to Present at American Podiatric Medical Association 2015 Annual Scientific Meeting
16 Jul 2015
Immunocore secures $320 million (£205 million) in Europe’s Largest Private Life Sciences Financing
08 Jul 2015
Serenus Biotherapeutics Names Renowned Industry Leader Skhumbuzo Ngozwana, M.D., as President